{
    "SPADE_UN_13448": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13448",
            "Peptide Name": "dCATH 18 (modified from dCATH)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "N/A",
            "Sequence": "FWQLVPLAIKIYRAWKRR",
            "Sequence Length": 18,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram-",
                "Anti-Gram+"
            ],
            "Target Organism": "[Ref.32698035] Gram-positive bacteria:S. aureus KCTC 1621 (MIC = 8 μM), S. epidermidis KCTC 1917 (MIC = 16 μM), B. subtilis KCTC 3068 (MIC = 8 μM);Resistant Gram-positive bacteria:MRSA CCARM 3089 (MIC = 32 μM), MRSA CCARM 3090 (MIC = 16 μM), MRSA CCARM 3095 (MIC = 32 μM), VREF ATCC 51559(MIC = 32 μM);Gram-negative bacteria:E. coli KCTC 1682 (MIC = 16 μM), P. aeruginosa KCTC 1637(MIC = 16 μM), S. typhimurium KCTC 1926 (MIC = 8 μM);Resistant Gram-negative bacteria:MDRPAd CCARM 2095 (MIC = 32 μM), MDRPA CCARM 2109 (MIC = 32 μM);Yeast:C. albicans KCTC 7965 (MIC = 16 μM), C. albicans KCTC 7121 (MIC = 16 μM).",
            "Hemolytic Activity": "[Ref.32698035] HC10 = 1.3 μM. Note:HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).",
            "Cytotoxicity": "[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 18 against human bone marrow SH-SY5Y cells is 102%, 83%, 75%, 52%, 23%, 9%, 7%.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Initially, four analog peptides were designed by truncating two, four, six, and eight amino acids at the N-terminal ends of dCATH peptide. dCATH and its truncated analogs could not adopt the amphipathic α-helical structure since the hydrophobic and charged residues were dispersed all around the molecule.",
            "Formula": "C115H178N32O21",
            "Mass": 2344.85,
            "PI": 11.73,
            "Net Charge": 5,
            "Hydrophobicity": -0.13,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Comments": "The peptide induces potent antimicrobial activity.",
            "Literature": [
                {
                    "Title": "Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin Plausible mechanism of bactericidal action and endotoxin neutralization",
                    "Pubmed ID": "32698035",
                    "Reference": "Eur J Med Chem. 2020 Oct 15;204112580. doi 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.",
                    "Author": "Kumar SD, Shin SY",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32698035"
                }
            ],
            "Frequent Amino Acids": "RAI",
            "Absent Amino Acids": "CDEGHMNOSTU",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 12,
            "Polar Residues": 10,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05992",
                    "Similarity": 1.0,
                    "Sequence": "KRFWQLVPLAIKIYRAWKRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_13449",
                    "Similarity": 1.0,
                    "Sequence": "QLVPLAIKIYRAWKRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_13450",
                    "Similarity": 1.0,
                    "Sequence": "VPLAIKIYRAWKRR"
                }
            ]
        }
    }
}